MetLife Investment Management’s Nano X Imaging NNOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.6K Buy
39,024
+18,007
+86% +$47.4K ﹤0.01% 2588
2025
Q4
$58.8K Sell
21,017
-17,020
-45% -$61.2K ﹤0.01% 2716
2025
Q3
$141K Sell
38,037
-304
-0.8% -$1.35K ﹤0.01% 2495
2025
Q2
$198K Buy
38,341
+6,636
+21% +$33.8K ﹤0.01% 2200
2025
Q1
$158K Sell
31,705
-710
-2% -$4.91K ﹤0.01% 2315
2024
Q4
$233K Hold
32,415
﹤0.01% 2224
2024
Q3
$197K Hold
32,415
﹤0.01% 2295
2024
Q2
$238K Buy
32,415
+8,337
+35% +$74.1K ﹤0.01% 2140
2024
Q1
$235K Hold
24,078
﹤0.01% 2101
2023
Q4
$153K Hold
24,078
﹤0.01% 2385
2023
Q3
$158K Hold
24,078
﹤0.01% 2332
2023
Q2
$373K Buy
24,078
+649
+3% +$9K ﹤0.01% 1889
2023
Q1
$135K Hold
23,429
﹤0.01% 2427
2022
Q4
$173K Hold
23,429
﹤0.01% 2338
2022
Q3
$269K Hold
23,429
﹤0.01% 2100
2022
Q2
$265K Buy
+23,429
New +$244K ﹤0.01% 2114

Other funds holding NNOX

MetLife Investment Management's NNOX Position: Q1 2026 in Review

MetLife Investment Management increased its Nano X Imaging (NNOX) stake by 86% in Q1 2026, buying an estimated $47.4K and bringing the position to 39,024 shares worth $88.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2588.

MetLife Investment Management first reported a position in NNOX in Q2 2022 and has held it in 16 quarters since. The position peaked at $373K in Q2 2023. 126 funds tracked by Wall St. Rank hold NNOX as of Q1 2026.

  • MetLife Investment Management held 39,024 shares of Nano X Imaging worth $88.6K as of Q1 2026.
  • MetLife Investment Management bought 18,007 Nano X Imaging shares in Q1 2026, an estimated $47.4K.
  • Nano X Imaging made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2588 holding.
  • MetLife Investment Management first reported a position in Nano X Imaging in Q2 2022 and has held it in 16 quarters since.
  • MetLife Investment Management's Nano X Imaging position peaked at $373K in Q2 2023.
  • 126 funds tracked by Wall St. Rank held Nano X Imaging as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.